AXIM BIOTECHNOLOGIES, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Axim Biotechnologies, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2011 to Q2 2024.
  • Axim Biotechnologies, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.27M, a 39% increase year-over-year.
  • Axim Biotechnologies, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$4.14M, a 56.1% increase year-over-year.
  • Axim Biotechnologies, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$8.06M, a 29.1% decline from 2022.
  • Axim Biotechnologies, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$6.24M, a 61.1% increase from 2021.
  • Axim Biotechnologies, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$16M, a 150% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$4.14M -$2.27M +$1.45M +39% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$5.59M -$292K +$2.47M +89.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-19
Q4 2023 -$8.06M -$1.9M -$1M -112% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 -$7.06M $328K +$2.36M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$9.42M -$3.72M -$2.5M -205% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 -$6.92M -$2.76M -$676K -32.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-19
Q4 2022 -$6.24M -$899K +$7.15M +88.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$13.4M -$2.03M +$1.26M +38.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$14.7M -$1.22M +$2.6M +68.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-20
Q1 2022 -$17.3M -$2.09M -$1.22M -141% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-20
Q4 2021 -$16M -$8.05M -$5.65M -236% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 -$10.4M -$3.29M -$1.39M -72.7% Jul 1, 2021 Sep 30, 2021 10-Q/A 2022-11-15
Q2 2021 -$8.99M -$3.83M -$3.75M -4720% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-11-15
Q1 2021 -$5.25M -$865K +$1.16M +57.4% Jan 1, 2021 Mar 31, 2021 10-Q/A 2022-11-15
Q4 2020 -$6.41M -$2.4M -$960K -66.9% Oct 1, 2020 Dec 31, 2020 10-K/A 2022-04-19
Q3 2020 -$5.45M -$1.91M -$1.04M -121% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 -$4.41M -$79.4K +$1.73M +95.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-22
Q1 2020 -$6.13M -$2.03M +$314K +13.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-22
Q4 2019 -$6.45M -$1.44M -$457K -46.7% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-26
Q3 2019 -$5.99M -$864K +$470K +35.2% Jul 1, 2019 Sep 30, 2019 10-Q/A 2020-11-27
Q2 2019 -$6.46M -$1.81M -$127K -7.54% Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-08-18
Q1 2019 -$6.33M -$2.34M +$421K +15.2% Jan 1, 2019 Mar 31, 2019 10-Q/A 2020-07-02
Q4 2018 -$6.75M -$979K +$459K +31.9% Oct 1, 2018 Dec 31, 2018 10-K/A 2020-05-20
Q3 2018 -$7.21M -$1.33M +$308K +18.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$7.52M -$1.68M -$1.11M -197% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$6.41M -$2.76M -$2.24M -427% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$4.17M -$1.44M -$254K -21.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-08
Q3 2017 -$3.91M -$1.64M +$142K +7.96% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$4.06M -$565K +$1.32M +70.1% Apr 1, 2017 Jun 30, 2017 10-Q/A 2018-08-17
Q1 2017 -$5.38M -$524K +$430K +45.1% Jan 1, 2017 Mar 31, 2017 10-Q/A 2018-05-18
Q4 2016 -$5.81M -$1.18M +$5.14M +81.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$10.9M -$1.78M -$80K -4.69% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 -$10.9M -$1.89M -$328K -21% Apr 1, 2016 Jun 30, 2016 10-Q/A 2017-09-14
Q1 2016 -$10.5M -$954K -$447K -88.2% Jan 1, 2016 Mar 31, 2016 10-Q/A 2017-09-14
Q4 2015 -$10.1M -$6.32M -$5.93M -1513% Oct 1, 2015 Dec 31, 2015 10-K/A 2017-09-14
Q3 2015 -$4.16M -$1.7M -$1.56M -1128% Jul 1, 2015 Sep 30, 2015 10-Q/A 2016-11-30
Q2 2015 -$2.6M -$1.56M -$1.52M -3386% Apr 1, 2015 Jun 30, 2015 10-Q/A 2016-08-25
Q1 2015 -$1.08M -$507K -$499K -6552% Jan 1, 2015 Mar 31, 2015 10-Q/A 2016-05-26
Q4 2014 -$583K -$392K -$331K -539% Oct 1, 2014 Dec 31, 2014 10-K/A 2016-04-18
Q3 2014 -$252K -$139K -$139K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-23
Q2 2014 -$113K -$44.8K -$22.5K -101% Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-08-27
Q1 2014 -$91K -$7.62K -$1.8K -31% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$89.2K -$61.3K -$57.2K -1413% Oct 1, 2013 Dec 31, 2013 10-K 2015-04-14
Q3 2013 -$32K $190* +$1.96K Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-18
Q2 2013 -$33.9K -$22.3K -$17.9K -406% Apr 1, 2013 Jun 30, 2013 10-Q/A 2014-08-26
Q1 2013 -$16K -$5.82K -$1.14K -24.4% Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-06-18
Q4 2012 -$14.9K -$4.05K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-04
Q3 2012 -$1.77K* +$2.25K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-18
Q2 2012 -$4.41K -$4.41K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$4.68K -$4.68K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 -$4.01K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
Q2 2011 $0 Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $0 Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.